Ryan Halsted

Stock Analyst at RBC Capital

(0.42)
# 5,150
Out of 5,182 analysts
12
Total ratings
25%
Success rate
-10.11%
Average return

Stocks Rated by Ryan Halsted

Doximity
Mar 9, 2026
Reiterates: Outperform
Price Target: $44
Current: $21.86
Upside: +101.28%
Medpace Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $522
Current: $520.65
Upside: +0.26%
IQVIA Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $221
Current: $172.54
Upside: +28.09%
Healthcare Services Group
Mar 3, 2026
Initiates: Sector Perform
Price Target: $22
Current: $19.20
Upside: +14.58%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $47$53
Current: $44.34
Upside: +19.53%
Evolent Health
Feb 25, 2026
Maintains: Sector Perform
Price Target: $5$3
Current: $2.56
Upside: +17.19%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $22.71
Upside: +36.50%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $17.52
Upside: +31.28%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $204.79
Upside: -